Other Science
476 articles
Pancreatic Cancer and Drug Interactions: What You Need to Know
Pharmacist Trevor Christ emphasizes the importance of sharing your medication list with your medical team and pharmacist.
Pancreatic Cancer Treatment During the COVID-19 Pandemic
During the March 2020 PancChat, pancreatic cancer experts discussed treatment during the COVID-19 pandemic, along with other important issues for patients.
Be Your Own Best Advocate
After being diagnosed with pancreatic cancer, long-term survivor Chris Parrish found she had to be her own advocate to get a chance at survival.
Stay in the Moment
Debbie Ryan is a long-term survivor of pancreatic cancer. The now-retired basketball coach applied her coaching philosophy to her treatment.
How Could This Happen to Me?
Michael Bailey felt his world turn sideways after a diagnosis of acinar cell pancreatic cancer. He had a pancreatectomy and chemotherapy.
For Tommy Thompson, the Commitment to Pancreatic Cancer Research Is Personal
Former Wisconsin Governor Tommy Thompson is an advocate for pancreatic cancer research because he lost both his brothers to the disease.
Being Persistent Led to my Cancer Diagnosis
Rod Devlin wasn’t getting an answer to his pain but he was persistent until he finally found a doctor that would give him a scan.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
mRNA Vaccine Shows Promising Results
Dr. Vinod Balachandran is testing an mRNA vaccine for pancreatic cancer using the same technology as COVID vaccines.
Taking Chances to Beat Pancreatic Cancer
With a family history of pancreatic cancer, Jay Bozick discovered he carries the BRCA2 mutation, which directed his treatment.
Using Humor to Face Pancreatic Cancer
Richard Liles has a stage IV pancreatic cancer diagnosis but feels it is very important to keep a sense of humor throughout.
Liquid Biopsies: What You Should Know
Three different liquid biopsy blood tests are under development or now available for pancreatic and other cancers.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
Comparing Chemotherapy Before with Chemotherapy After Pancreatic Cancer Surgery
Researchers are comparing effectiveness of chemotherapy before surgery (neoadjuvant) with chemotherapy after surgery (adjuvant).
Disappointing Results of a Phase II Trial Using Angiogenesis Inhibitor
Dr. Tanios Bekaii-Saab reports on the disappointing results of a trial combining an angiogenesis inhibitor and mFOLFIRINOX.